Placebo to match BMS 986165 tablet clinical trials

An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis

This study looks at a new medicine called deucravacitinib for people with moderate to severe plaque psoriasis. It aims to see if it's safe and effective over a long period. This is a follow-up study for people who have already tried the medicine.